-

AIS Healthcare Dispensed One Millionth Prescription in 2023

DALLAS--(BUSINESS WIRE)--As 2023 draws to a close, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it reached the milestone of dispensing one million prescriptions to patients living with chronic pain and other complex health conditions earlier this year. Since its inception more than 10 years ago, AIS Healthcare has been putting quality and safety first in the preparation and delivery of patient-specific prescriptions across the country.

At AIS Healthcare’s two 503A specialty compounding pharmacies, best-in-class licensed pharmacists go beyond state and industry standards to produce medications of the highest quality and sterility. Both facilities invest significant resources in people and processes to be able to produce prescriptions that exceed standards and expectations, using a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard—for patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Date (BUD). This gives providers confidence in the medications they prescribe and helps to reduce medication waste.

“AIS is proud to administer life-changing medications across the United States that improve patients’ quality of life. The achievement of dispensing one million prescriptions is a significant milestone. We remain committed to prioritizing patient safety in every aspect—from person to process to protocol. Our dedication to maintaining the highest standards of quality in healthcare is unwavering. We look forward to continuing the work of advancing quality and enabling patients to live better lives,” said Simon Castellanos, AIS Healthcare CEO.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com

Contacts

Simon Castellanos
877.443.4006

Industry:

AIS Healthcare

Release Versions
English

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U.S. Food and Drug Administration in June 2024, YIMMUGO® is now available at all AIC locations. The nationally accredited infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion center set...

Advanced Infusion Care Expands National Footprint by Launching a New Outpatient Infusion Center in Phoenix, AZ

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of patient-specific infusion therapy, proudly announces the launch of Advanced Infusion Care Centers (AICC), with the opening of its first location in Phoenix, AZ. This new center marks a major milestone in AIC’s continued growth and its mission to expand access to compassionate, high quality infusion care nationwide. The creation of AICC reflects the company’s strategic commitment to meet...

AIS Healthcare Acquires Preferred Excellent Care in Garden Grove, CA

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of patient-specific infusion therapy, has announced the acquisition of Preferred Excellent Care (“PEC”), a California-based pharmacy focused on infusion medications and services. PEC’s pharmacy in Garden Grove, CA is AIC’s sixth location from which the company will dispense essential medications and personalized care to patients across the United States with complex medical conditions like...
Back to Newsroom